A research group at Leipzig University Hospital, led by Professor Ulrich Hacker, together with scientists from Masaryk University in Brno, Czech Republic, has investigated what influences the life expectancy of patients with ...
Jul 11, 2022
0
36
Data from two large cancer centers in the United States have shown that the COVID-19 pandemic caused substantial disruption to clinical trials for cancer treatment and care.
Jun 15, 2022
0
3
ESMO, a professional organization for medical oncology, has developed a new evidence-based classification to guide research and interpretation of data on treatment de-escalation in oncology. The ESMO framework for the risk-adapted ...
May 10, 2022
0
19
A consensus reached by a lung clinical community within the International Cancer Benchmarking Partnership (ICBP), presented at the European Lung Cancer Congress (ELCC), 30 March-2 April 2022, has highlighted international ...
Mar 24, 2022
0
3
Patients who are at a higher risk of their lung cancer returning can be identified by a personalized blood test that is performed after treatment, according to researchers at the University of Cambridge.
Mar 18, 2022
0
72
ESMO, the leading professional organization for medical oncology, announces a new series of resources designed to guide physicians in areas of oncological practice not covered by guidelines, where current evidence is insufficient ...
Feb 28, 2022
0
1
Death rates from ovarian cancer are predicted to fall by 17 percent in the UK and by 7 percent in EU countries in 2022 compared to 2017, according to new research published in the journal Annals of Oncology today.
Jan 26, 2022
0
32
The first study to evaluate the clinical characteristics and outcomes of fully vaccinated patients with cancer who had breakthrough COVID-19 infections indicates they remained at high risk for hospitalization and death.
Dec 24, 2021
0
248
The immune checkpoint protein B7-H3 may be a promising new target for immunotherapy in treatment-resistant prostate cancers, according to two new studies led by researchers at the Johns Hopkins Kimmel Cancer Center. The studies ...
Nov 2, 2021
0
2
(HealthDay)—A novel deep learning model (DeepGrade [DG]) improves prognostic stratification for Nottingham histologic grade 2 (NHG 2) breast tumors, according to a study published online Sept. 29 in the Annals of Oncology.
Oct 4, 2021
0
0
